Medcaw Investments (MCI) Competitors GBX 2.80 -0.35 (-11.11%) As of 09/15/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock MCI vs. CMB, FA17, GUN, FAIR, CCPE, OTT, RGO, OXH, TORO, and SIHLShould you be buying Medcaw Investments stock or one of its competitors? The main competitors of Medcaw Investments include Cambria Africa (CMB), Fair Oaks Income (FA17), Gunsynd (GUN), Fair Oaks Income 2021 (FAIR), CVC Credit Partners European Opportunities (CCPE), Oxford Technology 3 Venture Capital Trust (OTT), RiverFort Global Opportunities (RGO), Oxford Technology VCT 2 (OXH), Chenavari Toro Income Fund (TORO), and Symphony International (SIHL). These companies are all part of the "asset management" industry. Medcaw Investments vs. Its Competitors Cambria Africa Fair Oaks Income Gunsynd Fair Oaks Income 2021 CVC Credit Partners European Opportunities Oxford Technology 3 Venture Capital Trust RiverFort Global Opportunities Oxford Technology VCT 2 Chenavari Toro Income Fund Symphony International Medcaw Investments (LON:MCI) and Cambria Africa (LON:CMB) are both small-cap financial services companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, media sentiment, institutional ownership, risk and dividends. Which has higher valuation & earnings, MCI or CMB? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedcaw InvestmentsN/AN/AN/A-£0.02-143.59Cambria Africa£1.41M0.00N/AN/AN/A Does the media refer more to MCI or CMB? In the previous week, Medcaw Investments had 1 more articles in the media than Cambria Africa. MarketBeat recorded 1 mentions for Medcaw Investments and 0 mentions for Cambria Africa. Medcaw Investments' average media sentiment score of 1.38 beat Cambria Africa's score of 0.00 indicating that Medcaw Investments is being referred to more favorably in the media. Company Overall Sentiment Medcaw Investments Positive Cambria Africa Neutral Is MCI or CMB more profitable? Cambria Africa has a net margin of 10.67% compared to Medcaw Investments' net margin of 0.00%. Cambria Africa's return on equity of 1.91% beat Medcaw Investments' return on equity.Company Net Margins Return on Equity Return on Assets Medcaw InvestmentsN/A -51.13% -10.82% Cambria Africa 10.67%1.91%1.29% SummaryCambria Africa beats Medcaw Investments on 5 of the 7 factors compared between the two stocks. Get Medcaw Investments News Delivered to You Automatically Sign up to receive the latest news and ratings for MCI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MCI vs. The Competition Export to ExcelMetricMedcaw InvestmentsAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£620K£1.46B£6.43B£2.59BDividend YieldN/A4.62%4.33%5.31%P/E Ratio-143.594,771.901,777.775,398.29Price / SalesN/A1,938.221,343.71264,607.79Price / CashN/A60.47127.9427.90Price / BookN/A1.352.108.05Net IncomeN/A£264.59M£1.23B£5.89B7 Day PerformanceN/A0.36%3.80%12.02%1 Month Performance-6.67%1.46%6.17%16.72%1 Year PerformanceN/A8.68%34.60%137.86% Medcaw Investments Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MCIMedcaw InvestmentsN/AGBX 2.80-11.1%N/AN/A£620KN/A-143.593Earnings ReportGap DownHigh Trading VolumeCMBCambria AfricaN/AN/AN/AN/A£2.45M£1.41M-3.759FA17Fair Oaks IncomeN/AGBX 0.59+6.3%N/AN/A£2.41M£34.59M7.65N/AGap UpGUNGunsyndN/AGBX 0.16+4.7%N/A+49.1%£2.21M£88K-186.901Gap UpHigh Trading VolumeFAIRFair Oaks Income 2021N/AGBX 0.53+0.6%N/A-2.8%£2.16M£34.59M6.85N/ANews CoverageHigh Trading VolumeCCPECVC Credit Partners European OpportunitiesN/AN/AN/AN/A£2.13MN/A0.00N/AGap DownOTTOxford Technology 3 Venture Capital TrustN/AN/AN/AN/A£2.13M-£85K-12.59203Gap DownRGORiverFort Global OpportunitiesN/AN/AN/AN/A£2.09M£433.48K3.1711,900Gap DownOXHOxford Technology VCT 2N/AGBX 7.50+36.4%N/AN/A£2.09M-£1.31M-144.23N/APositive NewsGap UpTOROChenavari Toro Income FundN/AGBX 0.66+0.5%N/A+23.0%£2.07M£37.05M5.78N/ASIHLSymphony InternationalN/AGBX 0.40+5.0%N/A+27.6%£2.04M£70.72M3.60N/AGap Down Related Companies and Tools Related Companies Cambria Africa Alternatives Fair Oaks Income Alternatives Gunsynd Alternatives Fair Oaks Income 2021 Alternatives CVC Credit Partners European Opportunities Alternatives Oxford Technology 3 Venture Capital Trust Alternatives RiverFort Global Opportunities Alternatives Oxford Technology VCT 2 Alternatives Chenavari Toro Income Fund Alternatives Symphony International Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:MCI) was last updated on 10/2/2025 by MarketBeat.com Staff From Our PartnersThis Biotech has a clinical approach that intrigues investorsThis biotech is gearing up for Phase 2 trials with a strategy to unlock multiple approvals from one study. ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | SponsoredAmerica’s Lost StocksPorter Stansberry says the real fortunes aren’t in Tesla, Amazon, or AI — but in a handful of overlooked “lost...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medcaw Investments Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Medcaw Investments With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
